×
About 7,440 results

ALLMedicine™ Cystitis Center

Research & Reviews  2,116 results

Echinacoside Ameliorates Cyclophosphamide-Induced Bladder Damage in Mice.
https://doi.org/10.1089/jmf.2021.K.0194
Journal of Medicinal Food; Shao Y, Liu Y et. al.

Jun 28th, 2022 - Interstitial cystitis (IC) is featured by apoptosis and chronic inflammation in bladder tissue. We aimed to evaluate the effect of echinacoside (ECH), which is known to modulate inflammation and apoptosis on IC using relevant models. We establishe...

Bearberry in the treatment of acute uncomplicated cystitis (BRUMI): protocol of a multi...
https://doi.org/10.1136/bmjopen-2021-057982
BMJ Open; Tóth B, Jávorházy A et. al.

Jun 25th, 2022 - Bearberry (Arctostaphylos uva-ursi) leaf is available as a treatment of uncomplicated cystitis in several European countries. The antimicrobial activity of its extracts and some of its individual constituents has been observed in vitro; however, t...

A pilot study on oral cyclosporine A in association with fulguration for the treatment ...
https://doi.org/10.1002/nau.24997
Neurourology and Urodynamics; Brière R, Bouchard F et. al.

Jun 23rd, 2022 - To evaluate the efficacy and safety of lesion fulguration in combination with cyclosporine A (CyA) as a maintenance therapy in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) with Hunner's lesion (HL). Retrospective observationa...

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
https://clinicaltrials.gov/ct2/show/NCT05127616

Jun 23rd, 2022 - Urologic chronic pelvic pain syndrome (UCPPS) encompasses several common, costly diagnoses including interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome that are poorly understood and inadequately treat...

Immunomodulation therapy offers new molecular strategies to treat UTI.
https://doi.org/10.1038/s41585-022-00602-4 10.1016/j.molimm.2003.10.005 10.1038/nri2194 10.3109/08830185.2010.529976 10.1038/s41585-021-00477-x 10.1038/nrurol.2010.101 10.1038/s41579-020-0324-0 10.1038/s41585-020-0350-8 10.1016/j.it.2021.01.003 10.1111/imr.12621 10.1371/journal.ppat.1001109 10.1126/scitranslmed.aaf1156 10.1371/journal.ppat.1005848 10.1038/s41598-018-28634-0 10.1084/jem.192.6.881 10.1086/318848 10.1002/eji.200535149 10.4049/jimmunol.0902386 10.1016/j.immuni.2014.02.015 10.1016/j.kint.2017.12.006 10.1152/ajprenal.00471.2016 10.1038/mi.2015.7 10.1073/pnas.1500374112 10.1038/mi.2015.44 10.1038/mi.2013.72 10.1093/infdis/143.3.404 10.1111/j.1365-3083.1985.tb01435.x 10.1016/S0022-5347(01)62142-6 10.1038/nrurol.2011.100 10.1172/JCI82424 10.1172/jci.insight.122998 10.1128/iai.46.3.839-844.1984 10.1016/S0022-5347(17)36260-2 10.1016/j.chom.2013.11.004 10.1371/journal.ppat.1005044 10.1038/nrurol.2010.190 10.1093/infdis/171.3.625 10.1038/nrmicro818 10.1086/514920 10.1016/S1369-5274(00)00242-3 10.1128/AAC.37.11.2255 10.1128/AAC.00862-20 10.1056/NEJMra1007755 10.1016/j.diagmicrobio.2013.11.011 10.3109/07853890109002101 10.1016/S0140-6736(76)90788-1 10.1056/NEJMp058032 10.1097/MOU.0000000000000364 10.3389/fped.2018.00277 10.1128/iai.57.11.3383-3388.1989 10.1016/S0966-842X(00)88941-6 10.1016/j.mpmed.2007.05.009 10.1056/NEJM196408272710905 10.1056/NEJM198605013141804 10.1097/01.CCM.0000194535.82812.BA 10.1136/bmj.l525 10.1001/archpedi.154.4.339 10.1007/s00467-003-1109-1 10.1111/j.1651-2227.2012.02785.x 10.1097/HJH.0000000000000234 10.1111/j.1574-6968.1980.tb05064.x 10.1093/infdis/158.1.29 10.1128/iai.59.12.4357-4362.1991 10.1128/CMR.4.1.80 10.1128/iai.37.1.286-291.1982 10.1093/clinids/17.3.448 10.1016/S0163-4453(88)93947-3 10.1038/35015091 10.1128/IAI.00075-08 10.1016/j.toxicon.2017.10.016 10.1016/0924-8579(94)90039-6 10.1111/j.1749-6632.1994.tb44247.x 10.4049/jimmunol.166.2.1148 10.1086/512620 10.1038/ki.2008.105 10.1007/s12223-014-0303-9 10.1126/science.282.5396.2085 10.1016/S0952-7915(99)00046-1 10.4049/jimmunol.178.8.4717 10.1016/j.mib.2007.12.001 10.1084/jem.183.3.1037 10.1046/j.1365-2958.1998.01017.x 10.1128/iai.58.9.3073-3077.1990 10.1073/pnas.93.18.9630 10.1073/pnas.96.14.8110 10.1074/jbc.M008610200 10.1074/jbc.M600877200 10.1371/journal.ppat.0030100 10.1038/nature01182 10.1371/journal.ppat.1001120 10.1128/iai.65.8.3451-3456.1997 10.1086/318848 10.1073/pnas.93.18.9827 10.1128/microbiolspec.UTI-0015-2012 10.1371/journal.ppat.1007671 10.1128/iai.61.2.602-609.1993 10.1111/j.1462-5822.2008.01230.x 10.1016/j.cell.2014.01.006 10.1371/journal.ppat.1004818 10.1128/IAI.00327-18 10.4049/jimmunol.165.9.5287 10.1371/journal.ppat.1002619 10.1038/35074106 10.1111/j.1744-313X.2007.00709.x 10.1016/j.chom.2007.05.007 10.1371/journal.pone.0005990 10.1371/journal.pone.0008300 10.1086/322030 10.1086/317599 10.1111/j.1523-1755.2005.00060.x 10.1172/JCI116650 10.1038/381077a0 10.1016/j.ebiom.2014.10.011 10.1038/s41423-020-0412-0 10.1172/jci.insight.97626 10.3389/fcimb.2017.00113 10.1152/ajprenal.00344.2014 10.1111/j.1744-313X.2012.01096.x 10.1016/j.juro.2006.10.037 10.1097/INF.0b013e3181ff84ff 10.1016/j.jpurol.2017.05.025 10.1016/j.jpeds.2010.08.006 10.1186/1471-2334-12-273 10.1016/j.juro.2014.03.092 10.1093/infdis/166.3.653 10.1007/s00467-007-0670-4 10.1056/NEJMoa1208760 10.1056/NEJMoa1209026 10.1021/ja505986a 10.1001/jama.2015.1241 10.1042/CS20050162 10.4155/tde.12.136 10.1196/annals.1281.008 10.1038/sj.cgt.7700931 10.1186/1741-7015-8-30 10.1136/bmj.h6544 10.1128/iai.58.7.2056-2060.1990 10.1172/JCI1861 10.1038/nm1407 10.1111/j.1348-0421.2011.00315.x 10.1128/IAI.70.6.3053-3060.2002 10.1007/s00109-007-0256-4 10.1038/ki.2011.109 10.1128/IAI.01393-13 10.1172/JCI71630 10.1016/S1097-2765(02)00708-6 10.1093/infdis/jiu577 10.1056/NEJMcp030027 10.1056/NEJMcp1104429 10.1056/NEJM199310283291808 10.1016/j.urology.2007.12.091 10.1016/j.urology.2008.09.014 10.1128/iai.40.1.265-272.1983 10.1128/iai.50.2.370-377.1985 10.1128/iai.55.2.373-380.1987 10.1128/iai.55.5.1224-1232.1987 10.1128/jcm.25.12.2253-2257.1987 10.1146/annurev.immunol.021908.132612 10.1016/j.immuni.2011.12.002 10.1371/journal.pone.0037689 10.1038/nri1391 10.1136/ard.2005.048371 10.1186/ar4303 10.1586/1744666X.2014.861325 10.1016/S2665-9913(20)30164-8 10.1038/ncomms10791 10.1016/S2665-9913(21)00216-2 10.1111/j.1432-2277.2008.00651.x 10.1172/JCI60777 10.1038/s41577-019-0147-2 10.1007/s002960050065 10.1371/journal.pone.0017360 10.1007/s00726-014-1736-9 10.1152/ajprenal.00187.2002 10.1016/S0002-9440(10)64944-9 10.1086/651275 10.1016/j.euros.2021.07.003 10.1016/S0090-4295(99)80327-6 10.1016/j.juro.2006.09.032 10.1016/j.eururo.2007.09.019 10.1186/1471-2490-9-16 10.1007/s10753-018-0888-2 10.1016/j.juro.2012.08.189 10.1517/13543780903379530 10.1128/iai.40.2.529-533.1983 10.1097/00005392-199909010-00067 10.1136/bmj.j4784 10.1371/journal.pmed.1002569 10.1038/nm1572 10.1172/JCI66451 10.1172/JCI140333 10.1038/nsmb763 10.1172/JCI152693 10.1172/JCI152693 10.1128/IAI.74.1.594-601.2006 10.1038/nm1734 10.1073/pnas.1215770110 10.1128/JCM.01227-09 10.1084/jem.20041442 10.1038/nrc904 10.1182/blood-2017-11-742577 10.1111/all.14149 10.1126/science.2911736 10.1002/dvdy.21841 10.1083/jcb.112.1.13 10.1038/s41587-020-00805-3 10.1093/infdis/139.3.329 10.1007/BF00256954 10.1038/298560a0 10.1038/328084a0 10.1038/nature22972 10.1038/265623a0 10.1073/pnas.0902179106 10.1126/scitranslmed.3003021 10.1038/s41579-020-00506-3 10.1128/iai.59.3.1153-1161.1991 10.1086/315258 10.1073/pnas.1606324113 10.1038/ki.1975.118 10.1128/iai.17.2.286-289.1977 10.1097/01.ju.0000116123.05160.43 10.1128/IAI.71.12.7164-7169.2003 10.1371/journal.ppat.1000586 10.1016/j.micpath.2017.07.037 10.1016/j.eursup.2009.07.002 10.1016/S0022-5347(01)64671-8 10.1016/S1473-3099(17)30108-1 10.1038/mi.2016.112 10.1111/bju.14606 10.1111/j.1464-410X.1990.tb14649.x 10.1128/mBio.00555-20 10.1016/j.biocel.2007.07.003 10.1128/IAI.00076-06 10.1016/j.mimet.2009.04.013 10.1128/IAI.00337-07 10.1128/JB.01744-06 10.1128/IAI.00752-12 10.1128/mr.47.4.510-550.1983 10.1016/S0022-3476(86)80110-X 10.1086/318857 10.1080/21645515.2020.1834807 10.1038/s41590-020-0688-3 10.1073/pnas.2026461118
Nature Reviews. Urology; Butler D, Ambite I et. al.

Jun 23rd, 2022 - Innovative solutions are needed for the treatment of bacterial infections, and a range of antibacterial molecules have been explored as alternatives to antibiotics. A different approach is to investigate the immune system of the host for new ways ...

see more →

Guidelines  4 results

Management of BK-virus infection - Swedish recommendations.
https://doi.org/10.1080/23744235.2019.1595130
Infectious Diseases (London, England); Dalianis T, Eriksson BM et. al.

Apr 24th, 2019 - BK-virus (BKV) associated nephropathy (BKVAN) and BKV associated haemorrhagic cystitis (HC) are complications of BKV infection/reactivation in renal and allogeneic haematopoietic stem cell transplantation (HSCT) patients, respectively. The task of...

Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline a...
https://doi.org/10.1016/j.juro.2015.01.086
The Journal of Urology; Hanno PM, Erickson D et. al.

Jan 28th, 2015 - The purpose of this amendment is to provide an updated clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome based upon data received since the publication of original guideline in 2011. A systematic lit...

AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syn...
https://doi.org/10.1016/j.juro.2011.03.064
The Journal of Urology; Hanno PM, Burks DA et. al.

Apr 19th, 2011 - To provide a clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. A systematic review of the literature using the MEDLINE® database (search dates 1/1/83-7/22/09) was conducted to identify peer reviewed...

International clinical practice guidelines for the treatment of acute uncomplicated cys...
https://doi.org/10.1093/cid/ciq257
Clinical Infectious Diseases : an Official Publication Of... Gupta K, Hooton TM et. al.

Feb 5th, 2011 - A Panel of International Experts was convened by the Infectious Diseases Society of America (IDSA) in collaboration with the European Society for Microbiology and Infectious Diseases (ESCMID) to update the 1999 Uncomplicated Urinary Tract Infectio...

see more →

Drugs  338 results see all →

Clinicaltrials.gov  315 results

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
https://clinicaltrials.gov/ct2/show/NCT05127616

Jun 23rd, 2022 - Urologic chronic pelvic pain syndrome (UCPPS) encompasses several common, costly diagnoses including interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome that are poorly understood and inadequately treat...

A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
https://clinicaltrials.gov/ct2/show/NCT05179460

Jun 22nd, 2022 - The purpose of this study is to evaluate incidence and prevalence rates of the study endpoints (pigmentary maculopathy [PM]/ pigmentary retinopathy [PR]/Any, PM/PR/ pentosan polysulfate sodium [PPS], and PM/PR/Non-PPS) in relation to PPS exposure,...

Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome
https://clinicaltrials.gov/ct2/show/NCT04401176

Jun 21st, 2022 - Recognition of interstitial cystitis (IC)/bladder pain syndrome (BPS) is increasing. There is a dire need to develop effective treatment options for these patients as it manifests as more than a physical disease, affecting general and psychologica...

A Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
https://clinicaltrials.gov/ct2/show/NCT05062902

Jun 9th, 2022 - The management of pelvic floor overactivity (PFOA) using focal BoNT injection has been gaining clinical interest. Evidence has shown that BoNT injections to the levator ani in patients with CPP generated a greater than 50% improvement in symptoms ...

Transvaginal Electrical Stimulation for Myofascial Pelvic Pain
https://clinicaltrials.gov/ct2/show/NCT05354869

Jun 7th, 2022 - This will be a prospective randomized trial. Sixty subjects with suspected myofascial pelvic pain will be recruited from the University of California, Los Angeles (UCLA) Center for Women's Pelvic Health. Patients will be informed of the opportunit...

see more →

News  197 results

UTIs in pregnancy: Managing urethritis, asymptomatic bacteriuria, cystitis, and pyelonephritis
https://www.mdedge.com/obgyn/article/250720/utis-pregnancy-managing-urethritis-asymptomatic-bacteriuria-cystitis-and
Patrick Duff, MD

Jan 13th, 2022 - CASE Pregnant woman with dysuria and suprapubic pain A 25-year-old primigravid woman at 18 weeks of gestation requests evaluation because of the acute onset of frequent urination, dysuria, urination hesitancy, and suprapubic pain on the morning fo.

Cystitis Drug Again Tied to Increased Risk of Maculopathy
https://www.medscape.com/viewarticle/963715

Nov 29th, 2021 - NEW YORK (Reuters Health) - A new study adds to growing evidence that use of pentosan polysulfate sodium (PPS) is associated with an increased risk of certain retinal disorders, researchers say. PPS is commonly prescribed to relieve bladder pain a...

Preprocedural Urinalyses Common but Often Not Indicated
https://www.medscape.com/viewarticle/956220

Aug 9th, 2021 - (Reuters Health) - Urinalyses are done within 30 days of 25% of common surgical procedures, and are not indicated in 89% of the cases, a U.S. study suggests. Researchers examined insurance claims data for 13.2 million inpatient and outpatient proc...

FDA Grants Priority Review to Nab-Sirolimus for Advanced Malignant PEComa
https://www.onclive.com/view/fda-grants-priority-review-to-nab-sirolimus-for-advanced-malignant-pecoma

Jul 26th, 2021 - The FDA has granted priority review to a new drug application (NDA) for the nanoparticle albumin-bound mTOR inhibitor nab-sirolimus (ABI-009) for the treatment of patients with malignant perivascular epithelioid cell neoplasm (PEComa).1 The app...

Rise in Advanced Cancers; End-of-Life Care for Kids; No Timeline for Grief
https://www.medpagetoday.com/hematologyoncology/othercancers/92458

May 6th, 2021 - As some experts predicted, the sharp decline in cancer screening during the height of the COVID-19 pandemic in 2020 has fueled an increase in the number of diagnoses of advanced-stage cancers. (ProPublica) The American Cancer Society addresses pat...

see more →

Patient Education  6 results see all →